HOME ABOUT PRODUCTS R&D INVESTORS MEDIA CAREERS CONTACT US About Board of Directors Management Manufacturing Press Releases Home About Press Releases Press Releases 2017 Feb 03 2017 ADIENNE Pharma & Biotech announces FDA Approval of TEPADINA Feb 03 2017 ADIENNE Pharma & Biotech annuncia l’approvazione di TEPADINA da parte di FDA Feb 03 2017 ADIENNE Pharma & Biotech erhält FDA-Zulassung für TEPADINA Jan 26 2017 ADIENNE Pharma & Biotech presenting the new subsidiary company 2016 Dec 5 2016 ADIENNE Pharma & Biotech presenting at 58th Annual ASH Meeting with session on Clinical AllogeneicTransplantation Dec 5 2016 ADIENNE Pharma & Biotech mit Präsentation zu klinischer Allotransplantation an der 58. Jahresversammlung der American Society of Hematology vertreten Dec 5 2016 ADIENNE Pharma & Biotech relaziona al 58° Annual ASH Meeting in una sessione dedicata al Trapianto Allogenico Site Services Disclaimer Accessibility Privacy Cookie Policy News Alert Site Map Share this page

HOME ABOUT PRODUCTS R&D INVESTORS MEDIA CAREERS CONTACT US About Board of Directors Management Manufacturing Press Releases Home About Manufacturing Manufacturing ADIENNE’s own production facility is located in Caponago close to Milan (Italy). It is the group’s center for manufacturing its product candidates for preclinical studies and clinical trials in preparation for regulatory approval and in preparation for commercialization. The facility, its processes, equipment and utilities use single-use disposable technology throughout the entire manufacturing process to control and prevent cross-contamination and hence fully comply with Good Manufacturing Practice (“GMP”)-requirements for manufacturing in a multi-product facility. The facility currently has the capability to produce biotechnological products in small batches for preclinical and clinical development and ADIENNE is planning to expand the manufacturing capabilities on-site. Site Services Disclaimer Accessibility Privacy Cookie Policy News Alert Site Map Share this page

HOME ABOUT PRODUCTS R&D INVESTORS MEDIA CAREERS CONTACT US About Board of Directors Management Manufacturing Press Releases Home About Board of Directors Board of Directors ADIENNE’s Board of Directors determines the company's major policies, including the investment objectives, financing, growth and distributions. Upon the first trading day of the shares on SIX Swiss Exchange, the Board of Directors of ADIENNE will consist of the following members: Antonio Francesco Di Naro, Chairman and President Antonio Lanzavecchia, Member Gilles Alberici, Member Silvana Minoretti, Member Site Services Disclaimer Accessibility Privacy Cookie Policy News Alert Site Map Share this page